COVID19 & Physical & Emotional Wellbeing of HCP

Status Completed

Clinical Trial Summary

The current COVID-19 pandemic has affected more than 3 million people worldwide across more than 200 countries. In the United Kingdom alone, at the end of April, there were almost 160,000 confirmed cases with more than 20,000 deaths. This has undoubtedly had significant physical and economical impact on the public. Healthcare workers are at high risk of developing life-threatening infectious diseases with increased exposure to patients' blood and bodily fluids. As such, health care workers arguably experience heightened anxiety and are predisposed to greater negative psycho-social impact from the current COVID-19 pandemic. The aim of this study is to evaluate the physical and psychological impact of COVID-19 on healthcare workers. This will be performed in two phases. In phase 1, investigators will collect information to evaluate the current psychiatric symptom profile (in particular, screening for anxiety or depression related symptoms), alcohol use, sleep-related complaints and overall well-being among healthcare workers who participate in this survey (with a focus on junior doctors). In addition the association of these mental health and behavioural parameters with the prevalence of stressful occasions, such as long-hours, unpredictability of work / redeployment, availability of personal protection equipment and concerns regarding family/relationship and self will be assessed. In phase 2, investigators will then reassess for the development or progression of psychiatric symptoms, use of alcohol and other substances, behavioural or interpersonal relationship changes as well as physical well-being at 6 weeks and 4- months. Physical well-being is assessed through the presence of suspected or confirmed COVID-19 infection and absence from work. Specifically, investigators will study the impact of variable provision of personal protection equipment (supply and training), extended working hours, and concern for well-being of family members, on work morale and anxiety levels. Another aim is also study the longer term mental health consequences of the current pandemic on health care workers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04433260
Study type	Observational
Source	Queen Mary University of London
Contact
Status	Completed
Phase
Start date	July 25, 2020
Completion date	March 31, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06267534` - Mindfulness-based Mobile Applications Program	N/A
Completed	`NCT04108689` - Internet-based Acceptance and Commitment Training for Elite Ice Hockey Players	N/A
Recruiting	`NCT06012084` - The Development and Evaluation of iCF-PWR for Healthy Siblings of Individuals With Cystic Fibrosis	N/A
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Recruiting	`NCT05227352` - Bio-Experiential Spaces for Mental Health in Healthworkers	N/A
Completed	`NCT03663075` - Effect of Group Education and Individual Counselling on Mental Health and Quality of Life in 45-60 Year Old Women	N/A
Completed	`NCT02480907` - Supporting Carers of Children and Adolescents With Eating Disorders in Austria (SUCCEAT)	N/A
Completed	`NCT02157766` - Wisconsin Center for the Neuroscience and Psychophysiology of Meditation	N/A
Completed	`NCT01155687` - Psychosocial Counseling in Afghanistan	N/A
Unknown status	`NCT01177696` - Intervention in Groups of Family Caregivers in Primary Health Care	N/A
Completed	`NCT01037946` - Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families	N/A
Completed	`NCT00700349` - Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa	N/A
Recruiting	`NCT03885401` - Enhanced Care Planning for Patients With Multiple Chronic Conditions	N/A
Completed	`NCT03118388` - Engaging Homeless Youth in Vocational Training to Meet Their Mental Health Needs	Phase 2
Completed	`NCT05061966` - The Digital Wellbeing Project	N/A
Completed	`NCT04026308` - Written vs Electronic Safety Planning Study	N/A
Completed	`NCT04546061` - Project Uplift: Substance Use and Mental Health Treatment for Young Sexual and Gender Minorities	N/A
Completed	`NCT05738109` - Evaluating the Efficacy of a 91-day Self-talk Mental Health Self-care Journal	N/A
Completed	`NCT03901274` - Partnering for Student Wellness	N/A
Not yet recruiting	`NCT05910580` - Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

COVID19 and Physical and Emotional Wellbeing of HCP — CoPE-HCP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms